- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07683676
Kinetic Control Training Versus Core Stability Exercises on Proprioception and Spatiotemporal Gait Parameters in Chronic Non-specific Low Back Pain (CNSLBP)
1. juli 2026 oppdatert av: Ola Adel Abd Elrazik Ibrahem, Cairo University
This study will be conducted to comapre between kinetic control training versus core stability exercises on proprioception and spatiotemporal gait parameters in chronic non-specific low back pain.
Studieoversikt
Status
Har ikke rekruttert ennå
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Chronic nonspecific low back pain (CNSLBP) represents a significant public health problem and an economic burden to employers.
It has become one of the most common problems in industrialized societies; it can affect 80% of people and has become the most common cause of functional limitation in individuals younger than 35 years.
Neuromuscular impairments and deficits are a primary contributor to the inception and chronicity of Low back pain with the psychological and social competes.
Specific-oriented retraining has a major effect in modulating biopsychosocial competes severity and peculiarity and crucial for controlling chronic Low back pain.
Interventions targeting neuromuscular impairments of the movement system are the most promising movement control concepts in these Low back pain treatment approaches.Kinetic Control Training (KCT), which focuses on movement control and muscle coordination, has emerged as a potential intervention for addressing the underlying motor control deficits associated with CNSLBP.
Exercises in managing CNSLBP.
For instance, a randomized controlled trial demonstrated that core stability training significantly improved back muscle strength and reduced pain intensity in young adults with chronic non-specific low back pain.
To the best of authors' knowledge, the effect of kinetic control versus core stability training on the spatiotemporal parameters of the gait has not been investigated yet.
So this study will be conducted to investigate this point.
Studietype
Intervensjonell
Registrering (Antatt)
60
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: ola Adel, phd
- Telefonnummer: 01207003453
- E-post: adelola191@gmail.com
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Subjects from both sexes diagnosed with chronic non-specific low back pain with uncontrolled movement related to kinetic control concept
- aging range from 18-45 years
- Pain provoked by movement.
- Pain for at least 3 months
- Pain with sufficient intensity (equal to or greater than 4 points on VAS).
Exclusion Criteria:
- History of previous spinal surgery.
- Patients with lumbar spine diseases (for example, disc prolapse or spondylolisthesis).
- Patients with abnormal neurological signs in lower extremities, radicular pain in the lower limb, hip arthrosis, congenital musculoskeletal deformity, female patients with pelvic lesions, and pregnant females.
- Red flag signs include unwanted weight loss, less than three months of symptom persistence, malignancies of the spine, spinal instability due to structural cause, for example: ligamentous sprain or spondylolisthesis.
- Gynaecological problems in females that may cause low back pain include coccydynia and hysterotomy
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Kinetic control group
Twenty patients will receive kinetic control training with conventional physical therapy three times a week for 8 weeks
|
Each patient in the group will be received kinetic control retraining with conventional physical therapy.
For each movement direction, specific control tests will be conducted.
The direction and site of the uncontrolled movement will be evaluated using special tests in accordance with the pain history of the patient.
conventional physical therapy includes Trans-cutaneous electric Nerve Stimulation (TENS), Heat by hot packs
|
|
Eksperimentell: Core stability exercises group
Twenty patients will receive core stability exercises with conventional physical therapy three times a week for 8 weeks
|
conventional physical therapy includes Trans-cutaneous electric Nerve Stimulation (TENS), Heat by hot packs
Core stability exercises include curl up (head and shoulders lifting), bridging exercise with leg elevation, and quadruped with arm and leg lift will be performed with maintaining the lumbar spine neutral.
each patient in that group will be received core stability exercises with conventional physical therapy,
|
|
Aktiv komparator: Conventional physical therapy exercise
twenty patients will receive conventional physical therapy three times a week for 8 weeks
|
conventional physical therapy includes Trans-cutaneous electric Nerve Stimulation (TENS), Heat by hot packs
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
lumber repositioning error (lumbar proprioception)
Tidsramme: up to 8 weeks
|
The iPhone® application will be used to assess lumbar repositioning error.
It will be placed vertically, halfway between the anterior superior and PSIS, just above the iliac crest, and fastened with a belt.
The initial location and the inclination of the inclinometer were both fixed at 0°.
There was a 0 to 30° range of motion (ROM).
The assessor gently guided the individual to a 30° flexion and instructed them to hold this posture for ten seconds.
After then, the participant actively went back to their starting location and subsequently did it three times.
|
up to 8 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
pain intensity
Tidsramme: up to 8 weeks
|
visual analogue scale will be used to assess pain intensity.t
consists of a 100-mm line with descriptive anchors representing extremes at each end, such as "no pain" and "worst pain imaginable.
|
up to 8 weeks
|
|
gait speed
Tidsramme: up to eight weeks
|
Using Kinovea (an open-source software) (version 0.9.5), a freeware motion analysis software will be used to retrieve all of the videos from the Sony Video camera.
normal, healthy gait speed for adults is generally between 1.0 m/s to 1.5 m/s.
|
up to eight weeks
|
|
cadence
Tidsramme: up to eight weeks
|
Cadence in gait is the rate at which steps are taken during locomotion, measured as steps per minute.Using Kinovea (an open-source software) (version 0.9.5), a freeware motion analysis software will be used to retrieve all of the videos from the Sony Video camera.
A healthy adult's normal walking cadence typically ranges between 100 to 120 steps per minute.
|
up to eight weeks
|
|
stride and step time
Tidsramme: up to eight weeks
|
Stride time is the total time taken to complete one full gait cycle.
Step time is the time it takes to complete a single step.Using Kinovea (an open-source software) (version 0.9.5), a freeware motion analysis software will be used to retrieve all of the videos from the Sony Video camera.
Normal walking gait for a healthy adult at a comfortable pace typically features a stride time of about 1.15 seconds and a step time of about 0.5 to 0.6 seconds
|
up to eight weeks
|
|
stride and step length
Tidsramme: up to eight weeks
|
Step length is the distance between the placement of one foot and the next placement of the opposite foot.
Stride length, conversely, covers the distance of two consecutive steps.
Using Kinovea (an open-source software) (version 0.9.5), a freeware motion analysis software will be used to retrieve all of the videos from the Sony Video camera.
A normal walking step length 58 to 76 cm.
A stride length averaging 52 to 60 inches.
|
up to eight weeks
|
|
COG vertical displacement
Tidsramme: up to eight weeks
|
Vertical displacement of the Center of Gravity (CoG) typically refers to the rhythmic, up-and-down movement of the body's mass center during the human gait cycle.
In a normal walking step, this vertical movement ranges to about 5 cm, helping conserve overall energy and maintain smooth motion.Using Kinovea (an open-source software) (version 0.9.5), a freeware motion analysis software will be used to retrieve all of the videos from the Sony Video camera.
|
up to eight weeks
|
|
life disability
Tidsramme: up to eight weeks
|
The WHOQOL-BREF will be used to assess life disability.
it is a 26-item survey evaluating Quality of Life (QoL) across four domains: Physical, Psychological, Social Relationships, and Environment.
Higher scores in each domain indicate a better perception of QoL
|
up to eight weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
10. juli 2026
Primær fullføring (Antatt)
1. mai 2027
Studiet fullført (Antatt)
1. mai 2027
Datoer for studieregistrering
Først innsendt
8. juni 2026
Først innsendt som oppfylte QC-kriteriene
1. juli 2026
Først lagt ut (Faktiske)
6. juli 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
6. juli 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
1. juli 2026
Sist bekreftet
1. juli 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- P.T.REC/012/006359
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .